Abiopharma

Revive Therapeutics Announces Closing of First Tranche of Private Placement and Debt Settlement

AVITA Medical to Host Investor Webinar Briefing

Best Bose Headphones for Superior Audio Quality in 2025

Best Epson Printer Models in 2025

Best JBL Speaker in 2025

Best Keyboards for Professional Users in 2025

Best LG Soundbar Models for Home Theaters (2025)

RadNet Reports Second Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA¹ and Revises Upwards 2025 Financial Guidance Ranges

ALT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Altimmune, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

IO Biotech, Inc. - IO Biotech to Announce Topline Results of Pivotal Phase 3 Trial of Cylembio® in Combination withKEYTRUDA® (pembrolizumab) as a First-Line Treatment for Patients with Advanced Melanoma

IO Biotech to Announce Topline Results of Pivotal Phase 3 Trial of Cylembio® in Combination with KEYTRUDA® (pembrolizumab) as a First-Line Treatment for Patients with Advanced Melanoma

Best AirPrint Printer Models for Home and Office Use

Best Beats Headphones In 2025

Best Portable Wireless Bluetooth Speakers In Terms Of Bass

Best Budget Gaming Laptops for Performance in 2025